CLINICAL_TRIALS
trial_result
· 2017-10-03
Clinical Trial Update: Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes [Phase 4]
Summary
Phase 4 trial assessing long-term response to sulfonylurea therapy in patients with KCNJ11-related neonatal diabetes completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Haukeland University Hospital | Conditions: Permanent Neonatal Diabetes Mellitus | Phase 4 | Status: COMPLETED